logo-loader

Integumen

Receive alerts
Market:
AIM
Market Cap:
£16.56 m
Price
1.69 GBX
Change
-3.98%
52 weeks high
2.58
52 weeks low
0.40

In brief

Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.

Deep dive We explore the investor case for growth companies

Snapshot

Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an artificial skin